🌿 Code targets medicinal cannabis telehealth 📞

PLUS: CBD vapes on TikTok, Little Green Pharma ships to Germany, and Legalise Cannabis NSW wins a seat

Good morning Greenies. Welcome to The Greenfields, your twice-weekly newsletter that keeps you ahead of the cannabis industry.

What’ve we got for you today?

  • Code targets medicinal cannabis telehealth 📞

  • Little Green Pharma ships to Germany 🇩🇪

  • Legalise Cannabis NSW wins a seat 🪑

  • CBD vapes being pushed on TikTok 🕰

Code targets medicinal cannabis telehealth

The Australian Medicinal Cannabis Association (AMCA) and the Society for Cannabis Clinicians Australian Chapter (SCCAC) have targeted telehealth clinics and practitioners in a draft code of conduct.

Some of the recommendations in the code include:

  1. Initial and follow up consultations should be in-person. Telehealth should only be used for people with no local access or difficulty attending a clinic in-person

  2. Once a month in-person follow up consultations until a safe dosage is found at which point they can be reduced to every 3-6 months

  3. Seeing patients in-person once every 12 months

  4. 30 minute consultations are preferred, with 20 minutes as a minimum. 15 minutes is considered insufficient for an initial assessment

  5. Prescribers are required to disclose any financial relationship they have with the clinic or the cannabis industry that may be a conflict of interest

If the code of conduct were adopted it would make it harder and more expensive for patients to access medicinal cannabis.

Part of the reason telehealth prescriptions for medicinal cannabis have been so successful is because of the difficulty of finding a doctor that can prescribe medicinal cannabis.

Three clinics are members of the AMCA: MiDispensary, Greencare, and ECS Clinics and all offer telehealth consultations. We are astounded they would shoot themselves in the foot like this, but maybe they don’t expect the code of conduct to go anywhere.

We’ve noticed almost zero promotion of the code of conduct from the groups involved. You can’t even find it on the AMCA website. They seem to be more enthused about a cannabis industry awards night… ðŸ¤·

Other recommendations include more consideration of the patients medical history, professional development of prescribers, and complying with other medical industry codes of conduct.

Like The Greenfields?

Send this email to a friend to make sure they don't fall behind in the cannabis business.

Are you the friend? Click the button to subscribe for free:

Little Green Pharma delivers to Germany

Little Green Pharma (ASX:LGP) have delivered their first shipment of cannabis to Ilios Sante in Germany.

The shipment was the first of a $2.3 million dollar deal with Ilios Sante. The deal runs over two years with 80% of the minimum purchase in the second year of the deal.

Ilios Sante and LGP signed the deal in July 2022. Since then LGP have been working on getting licences, vendor qualifications and finalising quality arrangements between the two parties.

LGP’s stock price jumped by 2.8% on the announcement, but finished the day flat. Investors might have remembered German imports of medicinal cannabis have slowed along with prescriptions.

Germany has also shelved plans to create a commercial cannabis market in favour of legalising home-grow and decriminalising possession.

Legalise Cannabis NSW wins a seat

The ABC election boffins have declared that Legalise Cannabis NSW is likely to win a seat in the NSW upper house.

Legalise Cannabis NSW’s upper house seat

Sitting in that seat will be Jeremy Buckingham, a former Greens MP for NSW.

Legalise Cannabis received 165k votes or 3.61% of the total votes.

With the win expected for Jeremy Buckingham Legalise Cannabis will have 2 seats in WA, 2 seats in Victoria and 1 in NSW.

Labor will need votes from 7 of the 12 cross-bench members of the upper house to pass legislation.

CBD Vapes on TikTok

CBD vapes are being advertised on TikTok, Facebook, and Instagram. The bubble-gum flavoured vapes are clearly targeted at children and require no ID check.

The TGA is investigating the people behind the vapes. It probably won’t be too hard for them to pin something on them considering advertising cannabis is not allowed because it is a medicine, and importing cannabis products requires a licence from the Office of Drug Control.

To make matters worse the vapes used the ‘Hubba-Bubba’ chewing gum brand to promote the products. Owners of the Hubba-Bubba brand Mars are also considering their legal options.

What did you think of todays newsletter?

A subscriber review:

Thanks for joining us on a walk through The Greenfields. We hope you've enjoyed it.

A quick heads up; there will not be a newsletter on the 25th of April due to ANZAC day.

We’ll see you again on 4/20! We can’t believe we’ve made it this far and appreciate everyone who has subscribed and keeps reading.

If you want more follow us on Twitter, Facebook, or LinkedIn.

DISCLAIMER: This newsletter is not financial or medical advice. It is strictly educational and is not investment advice or a solicitation to buy or sell anything or to make any financial decisions. Please do your own research and do not buy anything dodgy.

Reply

or to participate.